High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes

高通量筛选血管脂肪转运调节剂以治疗和预防糖尿病

基本信息

  • 批准号:
    10331230
  • 负责人:
  • 金额:
    $ 66.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-02-01 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Insulin resistance (IR) in skeletal muscle and other tissues is obligatory for the development of type 2 diabetes. Excess accumulation of incompletely oxidized non-esterified fatty acids (FAs) in muscle cells, i.e., lipotoxicity, is increasingly appreciated to underlie the development of IR. In parallel, branched chain amino acids (BCAAs) have recently moved front and center in the field of diabetes, as unbiased metabolomic profiling in large prospective epidemiological studies has shown that serum elevations of BCAAs predict IR and diabetes as much as 20 years prior to clinical presentation. We have now uncovered a novel molecular pathway that links these two observations. Active catabolism of the BCAA valine in skeletal muscle causes the paracrine secretion of a metabolite, 3-hydroxyisobutyrate (3-HIB), which promotes entry of FAs into skeletal muscle, and subsequent lipotoxicity. The identification of this pathway provides a novel entry point for the potential treatment of insulin resistance, orthogonal to most current insulin-based or insulin secretogenic therapies. The proposed project responds to PA-16-374 (Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK) and will identify lead-enabling small molecules that target this newly discovered pathway. Aim 1 use in silico and high-throughput screening to identify molecules that block production of 3HIB. Identified hits will be taken through a robust workflow of secondary counterscreens. In Aim 2, the molecules identified in Aim 1 will be tested for efficacy and safety in intact cells. In Aim 3, validated hits from Aims 1 and 2 will first be submitted to in vivo pharmacokinetic and pharmacodynamic studies. Viable candidates will then be tested for their ability to block lipid accumulation and insulin resistance in 3HIB-treated mice as well as in a pre- clinical high-fat fed model of insulin resistance. The proposed work represents a close collaboration between academia and a strong private sector team with a long history of successes. We propose a novel and provocative hypothesis, and a previously unexplored approach to understand and target lipotoxicity. Success would yield novel targets and potential lead compounds for the development of new therapeutics that address the root of insulin resistance.
项目总结/摘要 骨骼肌和其他组织中的胰岛素抵抗(IR)对于2型糖尿病的发展是必须的。 肌肉细胞中不完全氧化的非酯化脂肪酸(FA)的过量积累,即,脂毒性, 越来越多的人认识到这是IR发展的基础。同时,支链氨基酸(BCAA) 最近在糖尿病领域的前沿和中心,作为大规模无偏见的代谢组学分析, 前瞻性流行病学研究表明,血清支链氨基酸升高可预测IR和糖尿病, 早在临床表现前20年。我们现在已经发现了一种新的分子途径, 这两个观察。BCAA缬氨酸在骨骼肌中的主动催化引起旁分泌 代谢物3-羟基异丁酸酯(3-HIB)的分泌,其促进FA进入骨骼肌,和 随后的脂毒性。 该途径的鉴定为胰岛素抵抗的潜在治疗提供了新的切入点, 与大多数目前的基于胰岛素或胰岛素分泌原疗法正交。拟议项目响应 PA-16-374(用于发现治疗或成像药物的试验开发和筛选, 感兴趣的NIDDK),并将确定铅使小分子,针对这一新发现的 通路目的1利用计算机模拟和高通量筛选来鉴定阻断3 HIB产生的分子。 已确定的命中将通过二级反屏幕的强大工作流程进行。在目标2中,分子 将在完整细胞中测试目标1中鉴定的化合物的功效和安全性。在目标3中,目标1和2的确认命中率 将首先进行体内药代动力学和药效学研究。可行的候选人将在 测试了它们在3 HIB处理的小鼠以及预处理的小鼠中阻断脂质积累和胰岛素抵抗的能力。 临床高脂喂养胰岛素抵抗模型。 拟议的工作代表了学术界和强大的私营部门团队之间的密切合作, 有着悠久的成功历史。我们提出了一个新的和挑衅性的假设,和一个以前未探索的 了解和靶向脂毒性的方法。成功将产生新的目标和潜在的铅 这些化合物用于开发解决胰岛素抵抗根源的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zoltan P Arany其他文献

Zoltan P Arany的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zoltan P Arany', 18)}}的其他基金

Acetate and Endothelial Pathobiology
醋酸盐和内皮病理学
  • 批准号:
    10736268
  • 财政年份:
    2023
  • 资助金额:
    $ 66.13万
  • 项目类别:
Comprehensive quantification of fuel use in cold-induced thermogenesis in vivo
体内冷诱导生热过程中燃料使用的综合量化
  • 批准号:
    10637680
  • 财政年份:
    2023
  • 资助金额:
    $ 66.13万
  • 项目类别:
High-throughput screening for modulators of vascular fat transport to treat and prevent diabetes
高通量筛选血管脂肪转运调节剂以治疗和预防糖尿病
  • 批准号:
    10343859
  • 财政年份:
    2021
  • 资助金额:
    $ 66.13万
  • 项目类别:
Branched chain amino acids and pancreatic cancer
支链氨基酸与胰腺癌
  • 批准号:
    10436144
  • 财政年份:
    2020
  • 资助金额:
    $ 66.13万
  • 项目类别:
Branched chain amino acids in heart failure
支链氨基酸在心力衰竭中的作用
  • 批准号:
    10371891
  • 财政年份:
    2020
  • 资助金额:
    $ 66.13万
  • 项目类别:
Branched chain amino acids in heart failure
支链氨基酸在心力衰竭中的作用
  • 批准号:
    9977599
  • 财政年份:
    2020
  • 资助金额:
    $ 66.13万
  • 项目类别:
Branched chain amino acids in heart failure
支链氨基酸在心力衰竭中的作用
  • 批准号:
    10599927
  • 财政年份:
    2020
  • 资助金额:
    $ 66.13万
  • 项目类别:
Branched chain amino acids and pancreatic cancer
支链氨基酸与胰腺癌
  • 批准号:
    10688001
  • 财政年份:
    2020
  • 资助金额:
    $ 66.13万
  • 项目类别:
Keeping fat out of muscle - Role of Branched Amino Acids
保持肌肉中的脂肪——支链氨基酸的作用
  • 批准号:
    10186735
  • 财政年份:
    2018
  • 资助金额:
    $ 66.13万
  • 项目类别:
Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance
保持肌肉中的脂肪 - 支链氨基酸氨基酸在胰岛素抵抗中的作用
  • 批准号:
    10736605
  • 财政年份:
    2018
  • 资助金额:
    $ 66.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了